Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2007RD01 is a **natural extract** developed and investigated for use in the management of benign prostatic hyperplasia (BPH). It has been studied primarily as part of a combination therapy with saw palmetto lipidic extract to assess whether the combination is more effective than saw palmetto alone in patients with BPH. 2007RD01 itself is classified as a dietary supplement, with its precise botanical source, compositional details, and mechanism of action not publicly disclosed in available clinical trial records. Its role is suggestive of a supportive, possibly synergistic, botanical therapy for lower urinary tract symptoms associated with BPH in men[3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2007RD01.